June 27, 2019

Biosimilars – 2019 Mid-Year Update

In this webinar, life sciences attorneys John Adkisson, Tasha Francis, and Jenny Shmuel provide a mid-year review on the current status of the U.S. biosimilars space. Topics discussed include:

  • The U.S. biosimilars market: approvals, launches, and anticipated launches
  • FDA guidance
  • Select court cases and appellate guidance
  • Trends in IPRs in the biosimilars space
  • What’s on the horizon for biosimilars
Our hosts also review recent legislative proposals with potential impact on the biosimilars market.
No Comments

Sorry, the comment form is closed at this time.

Fill out the form below to receive our monthly newsletter and updates on your selected areas of interest. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of the email.

  • Fish & Richardson P.C. is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the services you requested from us. From time to time, we would like to contact you about our services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below.
  • In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.
  • You can unsubscribe from these communications at any time. This can be done by clicking the unsubscribe link at the bottom of marketing emails you receive from us, or by emailing stating that you would like to be unsubscribed.
  • This field is for validation purposes and should be left unchanged.